Therapeutic drug monitoring of vancomycin: a guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society | Zendy

Zhikang Ye | Zendy; Yaolong Chen | Zendy; Ken Chen | Zendy; Xianglin Zhang | Zendy; Guanhua Du | Zendy; Bei He | Zendy; Dakui Li | Zendy; You-ning Liu | Zendy; Kehu Yang | Zendy; Yingyuan Zhang | Zendy; Suodi Zhai | Zendy

Open Access

Therapeutic drug monitoring of vancomycin: a guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society

Author(s) -

Zhikang Ye,

Yaolong Chen,

Ken Chen,

Xianglin Zhang,

Guanhua Du,

Bei He,

Dakui Li,

You-ning Liu,

Kehu Yang,

Yingyuan Zhang,

Suodi Zhai

Publication year - 2016

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkw254

Subject(s) - vancomycin , guideline , therapeutic drug monitoring , medicine , intensive care medicine , drug , pharmacology , pathology , biology , bacteria , genetics , staphylococcus aureus

Guideline development should be based on the quality of evidence, balance of benefits and harms, economic evaluation and patients' views and preferences. Therefore, these factors were considered in the development of a new guideline for therapeutic drug monitoring (TDM) of vancomycin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research